- Release Date: 31/07/13 08:25
- Summary: Quarterly Activities and Cashflow Report
- Price Sensitive: Yes
- Download Document 5.75MB
- Forums
- ASX - By Stock
- DEG
- Ann: Quarterly Activities and Cashflow Report
Ann: Quarterly Activities and Cashflow Report
Featured News
Add DEG (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.39 |
Change
0.015(1.09%) |
Mkt cap ! $3.319B |
Open | High | Low | Value | Volume |
$1.37 | $1.40 | $1.36 | $5.391M | 3.892M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 61632 | $1.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 86094 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 61632 | 1.380 |
6 | 148129 | 1.375 |
4 | 90360 | 1.370 |
1 | 8470 | 1.365 |
5 | 120229 | 1.360 |
Price($) | Vol. | No. |
---|---|---|
1.395 | 86094 | 8 |
1.400 | 154486 | 13 |
1.405 | 146101 | 5 |
1.410 | 63849 | 5 |
1.415 | 41086 | 5 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
DEG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online